A Missouri woman is one of the latest in a mounting number of patients who may have been adversely affected by power morcellators. The devices have been linked to the spread of cancerous cells throughout the abdominal cavity. The complaint filed in the US District Court for the Western District of Missouri on behalf of Ms. Carl Cecilia Merrill on December 3, 2014, alleges that a device manufactured by Johnson & Johnson caused the spread of leiomyosarcoma, a rare cancer of the uterine and abdominal muscles, leading to her death in August. It is believed that the power morcellator accelerated the spread of an undiagnosed uterine cancer from its most treatable stage to its most lethal in a relatively short period of time.
The FDA now believes that as many as 1 in 350 women who have undergone a laparoscopic uterine fibroid removal may have undiagnosed cancer. As a result, the FDA began discouraging the use of the devices in April 2014. On November 24, 2014 began issuing a “black box warning” for any devices remaining on the market; condemning their use. Currently, the new warnings prohibit use in all but a minority of the women undergoing laparoscopic uterine morcellation procedures annually.
Until recently 1 out of 10,000 women were said to have cancerous fibroids that were previously undiagnosed. However, new studies show that the number is closer to 1 out of 350, putting many more women at a risk of being diagnosed with an advanced stage of cancer after undergoing this routine surgery. If you, or a loved one, have undergone a hysterectomy with a morcellator, and you have seen cancer spread through your abdomen region, you may be eligible for compensation. Contact a morcellation attorney from Arentz Law by filling out the contact form on this page, or by calling 1-800-305-6000 to schedule your no obligation initial case review.